论文部分内容阅读
长沙地区支气管哮喘患病率为7.89％。我们于1975年曾应用死卡介苗皮上划痕治疗支气管哮喘取得一定效果。由于长期皮上划痕致皮肤瘢痕、溃疡、继发感染等,患者不易坚持治疗,对并有肺部感染者单用死卡介苗,有时难以控制。针对这些问题,我们和湘潭制药厂于1984年开始研制了口服卡虎素(即死卡介苗与虎耳草复方制剂),并用此制剂治疗91例支气管哮喘,结果如下:
The prevalence of bronchial asthma in Changsha was 7.89%. We have been in the application of dead BCG scratch scratch treatment of bronchial asthma achieved some results. Due to long-term skin scars caused by skin scars, ulcers, secondary infections, the patient is not easy to adhere to treatment, and those with pulmonary infection alone with dead BCG, and sometimes difficult to control. In response to these problems, we and Xiangtan Pharmaceutical Factory in 1984 began the development of oral kasugamycin (ie dead BCG and saxifrage compound), and with this preparation of 91 cases of bronchial asthma, the results are as follows: